Core Viewpoint - Deutsche Bank reported record profits for Q4 2025, with a net income of €1.3 billion ($1.56 billion), exceeding analyst expectations of €1.12 billion [1][5]. Financial Performance - Q4 total revenue reached €7.73 billion, a 7.1% increase year-over-year, aligning closely with LSEG's estimate of €7.72 billion [1]. - The bank's net profit for 2025 was €6.12 billion ($7.3 billion), significantly higher than the previous year's €2.7 billion and slightly above analyst expectations of nearly €6 billion [1]. - Earnings per share for Q4 were €0.76, surpassing the market expectation of €0.55 [1]. Dividend and Share Buyback - Management plans to propose a dividend of €1 per share for 2025 at the annual shareholder meeting in May 2026, totaling €1.9 billion, a 50% increase from the previous year's dividend of €0.68 per share [5]. - The bank announced a €1 billion share buyback plan, which, combined with the dividend, will result in a payout of 50% of last year's profits [5]. Business Segment Performance - Fixed income and foreign exchange trading revenue grew by 6% year-over-year, marking the best Q4 performance ever, exceeding the expected 4% growth [5]. - Despite strong trading performance, consulting and loan issuance declined by 4%, partially offsetting the overall growth [6]. Legal and Regulatory Challenges - The bank faced a regulatory raid related to a money laundering investigation, which overshadowed its strong performance [7]. - The investigation is focused on transactions involving bank employees and companies linked to sanctioned individual Roman Abramovich from 2013 to 2018 [7]. Future Outlook - Deutsche Bank expects revenue to rise to approximately €33 billion in 2026, driven by growth in loans and fees [8]. - The bank's CET1 capital ratio for Q4 was 14.2%, slightly down from 14.5% in the previous quarter but up from 13.8% year-over-year [9]. - The bank's three-year financial plan concluded in 2025, achieving a tangible equity return target of over 10% [9].

Core Insights - The French drugmaker announced a share buyback program following an increase in sales and earnings for the fourth quarter [1] Group 1 - The company's sales and earnings for the fourth quarter showed a positive trend, indicating strong financial performance [1]

从回购实施进展来看，洁特生物、华之杰、壹石通回购金额最高，分别回购497.14万元、294.6万元、 230.7万元。 每经AI快讯，Wind数据显示，1月29日，6家公司共发布6个股票回购相关进展。其中，4家公司披露股 票回购实施进展，2家公司回购方案已实施完毕。 （文章来源：每日经济新闻） 从已完成回购来看，键邦股份、华鲁恒升分别回购1509.78万元、54.24万元。 ...

Group 1 - The company, Jieli Trading (08017), announced a share buyback plan on January 28, 2026, involving an expenditure of HKD 1.5258 million to repurchase 1 million shares [1] - The repurchase price per share ranges from HKD 1.48 to HKD 1.57 [1]

Glowing upward arrows and rising candlestick chart symbolizing CoStar’s share buyback boost and rebound. Key Points Automatic Data Processing, CoStar Group, and Paychex all expanded buyback capacity after steep share-price declines. Each authorization equals a meaningful slice of market cap, suggesting management confidence at current levels. CoStar stands out for pairing a large repurchase plan with updated forward commentary as it ramps investment. Interested in CoStar Group, Inc.? Here are five sto ...

（编辑 王雪儿） 证券日报网讯 1月28日，光大证券在互动平台回答投资者提问时表示，公司一直以来非常关注和重视公 司的股价表现。根据证券法规定，证券从业人员不得买卖股票。公司也会根据市场和行业趋势、自身实 际情况积极研究股票回购的法律法规及相关制度。公司将继续加强经营管理，实现高质量发展，努力提 升业绩和股东回报水平；公司合法合规地开展市值管理，将继续加强与市场分析师、投资者的密切沟通 交流，进一步提升资本市场对公司投资价值的发现和认可，使公司股价更合理地体现公司价值。 ...

格隆汇1月28日｜阿斯麦(ASML.US)宣布将在2028年底前回购总额高达120亿欧元的股票。阿斯麦预计 2026年毛利率在51%至53%，市场预估52.9%。 ...

阿斯麦预计2026年毛利率在51%至53%，预估52.9%。阿斯麦宣布将在2028年底前回购总额高达120亿欧 元的股票。 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 风险提示及免责条款 ...

每经AI快讯，Wind数据显示，1月27日，共40只港股获公司回购。其中，舜宇光学科技、吉利汽车、碧 桂园服务回购金额最大，分别获公司回购9678.61万港元、3786.53万港元、944.33万港元。截至1月27 日，今年已有114只港股获公司回购，7只个股年内累计回购金额超亿港元。其中，腾讯控股、小米集 团-W、舜宇光学科技年内累计回购金额最大，分别获公司回购63.58亿港元、23.90亿港元、9.66亿港 元。 （文章来源：每日经济新闻） ...

Summary of Key Points Core Viewpoint - On January 28, a total of 14 companies announced 15 stock repurchase updates, indicating a trend of companies engaging in buyback programs to enhance shareholder value [1]. Group 1: First Disclosure of Buyback Plans - Two companies, Greenmei and Davi Co., disclosed their stock repurchase plans for the first time, with proposed buyback amounts not exceeding 3.03 million and 0.23 million respectively [1]. Group 2: Approval of Buyback Plans by Shareholders - Three companies, New Open Source, Guangdong Hongtu, and Guangji Pharmaceutical, had their buyback plans approved by shareholders, with the highest proposed repurchase amounts being 50 million, 18.10 million, and 0.42 million respectively [1]. Group 3: Progress of Buyback Implementation - The companies with the highest buyback amounts in progress include Heng Rui Pharmaceutical, Jingji Agricultural, and Xingfa Group, with repurchase amounts of 605 million, 94.46 million, and 65.54 million respectively [1]. Group 4: Completed Buybacks - The companies that have completed their buybacks with the highest amounts are Huitai Medical, Xiye Co., and Aopu Technology, with completed repurchase amounts of 250 million, 7.01 million, and 0.85 million respectively [1].